AbbVie: High Yield At A Low P/E
July 17, 2021 at 19:28 PM EDT
Over the first half of this year, pharmaceutical giant AbbVie has traded in a narrow range while meme stocks, cryptocurrencies, and other get-rich-quick schemes have diverted investor attention away from more conventional equities.